FI101306B1 - Menetelmä kudostyyppisen plasminogeeniaktivaattorin analogien, joissa on muokatut kasvutekijädomeenit, valmistamiseksi - Google Patents
Menetelmä kudostyyppisen plasminogeeniaktivaattorin analogien, joissa on muokatut kasvutekijädomeenit, valmistamiseksiInfo
- Publication number
- FI101306B1 FI101306B1 FI882627A FI882627A FI101306B1 FI 101306 B1 FI101306 B1 FI 101306B1 FI 882627 A FI882627 A FI 882627A FI 882627 A FI882627 A FI 882627A FI 101306 B1 FI101306 B1 FI 101306B1
- Authority
- FI
- Finland
- Prior art keywords
- analogs
- growth factor
- plasminogen activator
- tissue
- preparation
- Prior art date
Links
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title abstract 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title abstract 2
- 239000003102 growth factor Substances 0.000 title abstract 2
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 abstract 3
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 229960000187 tissue plasminogen activator Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5806187A | 1987-06-04 | 1987-06-04 | |
| US5806187 | 1987-06-04 | ||
| US16284788A | 1988-03-02 | 1988-03-02 | |
| US16284788 | 1988-03-02 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI882627A0 FI882627A0 (fi) | 1988-06-03 |
| FI882627A FI882627A (fi) | 1988-12-05 |
| FI101306B1 true FI101306B1 (fi) | 1998-05-29 |
| FI101306B FI101306B (fi) | 1998-05-29 |
Family
ID=26737188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI882627A FI101306B (fi) | 1987-06-04 | 1988-06-03 | Menetelmä kudostyyppisen plasminogeeniaktivaattorin analogien, joissa on muokatut kasvutekijädomeenit, valmistamiseksi |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5403734A (no) |
| EP (1) | EP0293936B1 (no) |
| JP (1) | JPS6485079A (no) |
| KR (1) | KR0135427B1 (no) |
| AT (1) | ATE118815T1 (no) |
| AU (1) | AU625752B2 (no) |
| CA (1) | CA1341446C (no) |
| DE (1) | DE3853100T2 (no) |
| DK (1) | DK302388A (no) |
| ES (1) | ES2069536T3 (no) |
| FI (1) | FI101306B (no) |
| IE (1) | IE67036B1 (no) |
| NO (1) | NO179874C (no) |
| NZ (1) | NZ224914A (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756093A (en) * | 1985-04-22 | 1998-05-26 | Genentech, Inc. | Tissue plasminogen activator variants |
| US5714372A (en) * | 1985-04-22 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator variants |
| US5736134A (en) * | 1985-04-22 | 1998-04-07 | Genentech, In.C | Tissue plasminogen activator variants |
| DE3851259T2 (de) * | 1987-06-04 | 1994-12-15 | Zymogenetics Inc | Mutierter t-PA mit Kringle-Ersatz. |
| GB8815135D0 (en) * | 1988-06-24 | 1988-08-03 | British Bio Technology | Proteins & nucleic acids |
| US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
| US5108901A (en) * | 1988-09-02 | 1992-04-28 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| US5258180A (en) * | 1988-09-02 | 1993-11-02 | Genetech, Inc. | Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment |
| US5087572A (en) * | 1989-12-01 | 1992-02-11 | Genentech, Inc. | Dna encoding human plasminogen modified at the cleavage site |
| US5190756A (en) * | 1989-12-01 | 1993-03-02 | Genentech, Inc. | Methods and materials for expression of human plasminogen variant |
| JPH0595786A (ja) * | 1991-10-07 | 1993-04-20 | Green Cross Corp:The | 変異ヒトプロウロキナーゼ |
| DE10199044I2 (de) * | 1992-06-03 | 2006-02-09 | Genentech Inc | Varianten des Gewebeplasminogenaktivators mit verbesserter Therapeutischer wirkung |
| US6706504B1 (en) | 1996-11-12 | 2004-03-16 | The Scripps Research Institute | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| CA2807749C (en) * | 2010-08-05 | 2023-02-28 | Council Of Scientific & Industrial Research | Protein fusion constructs possessing thrombolytic and anticoagulant properties |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL68561A (en) * | 1982-05-05 | 1991-01-31 | Genentech Inc | Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof |
| EP0125254A1 (en) * | 1982-10-28 | 1984-11-21 | Beecham Group Plc | Enzyme derivatives and their use in the treatment of thrombosis |
| DK149786A (da) * | 1985-04-04 | 1986-10-04 | Beecham Group Plc | Proteolytisk enzym |
| FR2581652B1 (fr) * | 1985-04-22 | 1989-12-22 | Genentech Inc | Nouveaux mutants de l'activateur tissulaire du plasminogene humain |
| US4916071A (en) * | 1985-08-14 | 1990-04-10 | American Home Products Corporation | Poly-kringle plasminogen activator |
| JP2527454B2 (ja) * | 1986-01-31 | 1996-08-21 | ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド | 新しい血栓溶解タンパク質 |
| US5376547A (en) * | 1987-01-30 | 1994-12-27 | American Home Products Corporation | Des-epidermal growth factor plasminogen activators |
-
1988
- 1988-06-03 ES ES88108951T patent/ES2069536T3/es not_active Expired - Lifetime
- 1988-06-03 DK DK302388A patent/DK302388A/da not_active Application Discontinuation
- 1988-06-03 EP EP88108951A patent/EP0293936B1/en not_active Expired - Lifetime
- 1988-06-03 NO NO882454A patent/NO179874C/no not_active IP Right Cessation
- 1988-06-03 AT AT88108951T patent/ATE118815T1/de not_active IP Right Cessation
- 1988-06-03 IE IE168088A patent/IE67036B1/en not_active IP Right Cessation
- 1988-06-03 DE DE3853100T patent/DE3853100T2/de not_active Expired - Fee Related
- 1988-06-03 FI FI882627A patent/FI101306B/fi active IP Right Grant
- 1988-06-04 KR KR1019880006717A patent/KR0135427B1/ko not_active IP Right Cessation
- 1988-06-04 JP JP63138233A patent/JPS6485079A/ja active Granted
- 1988-06-06 CA CA000568718A patent/CA1341446C/en not_active Expired - Fee Related
- 1988-06-06 AU AU17430/88A patent/AU625752B2/en not_active Ceased
- 1988-06-07 NZ NZ224914A patent/NZ224914A/xx unknown
-
1991
- 1991-10-15 US US07/776,854 patent/US5403734A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR0135427B1 (ko) | 1998-04-23 |
| AU1743088A (en) | 1988-12-08 |
| EP0293936A3 (en) | 1989-09-20 |
| JPH0448434B2 (no) | 1992-08-06 |
| EP0293936A2 (en) | 1988-12-07 |
| JPS6485079A (en) | 1989-03-30 |
| ES2069536T3 (es) | 1995-05-16 |
| FI882627A0 (fi) | 1988-06-03 |
| NO882454L (no) | 1988-12-05 |
| NO179874C (no) | 1997-01-02 |
| CA1341446C (en) | 2003-11-18 |
| US5403734A (en) | 1995-04-04 |
| DE3853100D1 (de) | 1995-03-30 |
| NO882454D0 (no) | 1988-06-03 |
| DK302388D0 (da) | 1988-06-03 |
| FI882627A (fi) | 1988-12-05 |
| NZ224914A (en) | 1991-02-26 |
| AU625752B2 (en) | 1992-07-16 |
| ATE118815T1 (de) | 1995-03-15 |
| IE67036B1 (en) | 1996-05-15 |
| IE881680L (en) | 1988-12-04 |
| FI101306B (fi) | 1998-05-29 |
| DE3853100T2 (de) | 1995-08-03 |
| DK302388A (da) | 1989-02-03 |
| KR890000521A (ko) | 1989-03-15 |
| NO179874B (no) | 1996-09-23 |
| EP0293936B1 (en) | 1995-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI101306B1 (fi) | Menetelmä kudostyyppisen plasminogeeniaktivaattorin analogien, joissa on muokatut kasvutekijädomeenit, valmistamiseksi | |
| FR2591485B1 (fr) | Compositions stabilisees contenant l'activateur du plasminogene du tissu humain. | |
| DK135887D0 (da) | Human-vaevstype-plasminogenaktivator-polypeptider og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
| FI882628A0 (fi) | T-pa mutaterad genom remplacering av en region bestaoende av tre disulfidbindningar (kringle). | |
| GB8806737D0 (en) | Therapeutic composition & method | |
| IL85189A (en) | Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them | |
| DE59005128D1 (de) | t-PA pro STABILISIERUNG. | |
| NO902405D0 (no) | Vevplasminogenaktivatorderivat, dna-sekvens og ekspresjonsplasmid, samt fremgangsmaate for fremstilling av plasmidet. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Owner name: ZYMOGENETICS, INC. Owner name: NOVO INDUSTRI A/S Owner name: EISAI CO., LTD. |